Medy-Tox Inc. (086900.KQ)
KRW 124900.0
(-2.42%)
KRW 124900.0
(-2.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 611.62 Billion KRW | 2.57% |
| 2022 | 596.28 Billion KRW | 3.22% |
| 2021 | 577.69 Billion KRW | 23.5% |
| 2020 | 467.76 Billion KRW | 10.97% |
| 2019 | 421.52 Billion KRW | 6.71% |
| 2018 | 395.01 Billion KRW | 3.69% |
| 2017 | 380.94 Billion KRW | 17.56% |
| 2016 | 324.03 Billion KRW | 59.19% |
| 2015 | 203.55 Billion KRW | 20.79% |
| 2014 | 168.51 Billion KRW | 112.19% |
| 2013 | 79.41 Billion KRW | 12.59% |
| 2012 | 70.53 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 633.49 Billion KRW | 3.58% |
| 2024 Q2 | 613.93 Billion KRW | -3.09% |
| 2023 Q4 | 611.62 Billion KRW | -0.9% |
| 2023 FY | 611.62 Billion KRW | 2.57% |
| 2023 Q1 | 600.83 Billion KRW | 0.76% |
| 2023 Q2 | 608.02 Billion KRW | 1.2% |
| 2023 Q3 | 617.16 Billion KRW | 1.5% |
| 2022 FY | 596.28 Billion KRW | 3.22% |
| 2022 Q2 | 622.96 Billion KRW | 3.29% |
| 2022 Q1 | 603.1 Billion KRW | 4.4% |
| 2022 Q4 | 596.28 Billion KRW | -3.38% |
| 2022 Q3 | 617.15 Billion KRW | -0.93% |
| 2021 Q3 | 599.16 Billion KRW | -7.49% |
| 2021 Q4 | 577.69 Billion KRW | -3.58% |
| 2021 Q2 | 647.66 Billion KRW | 17.04% |
| 2021 Q1 | 553.37 Billion KRW | 18.3% |
| 2021 FY | 577.69 Billion KRW | 23.5% |
| 2020 Q4 | 467.76 Billion KRW | 1.63% |
| 2020 FY | 467.76 Billion KRW | 10.97% |
| 2020 Q3 | 460.27 Billion KRW | -1.87% |
| 2020 Q2 | 469.05 Billion KRW | 3.54% |
| 2020 Q1 | 453.01 Billion KRW | 7.47% |
| 2019 Q1 | 402.58 Billion KRW | 1.92% |
| 2019 Q2 | 408.47 Billion KRW | 1.46% |
| 2019 Q3 | 418.36 Billion KRW | 2.42% |
| 2019 Q4 | 421.52 Billion KRW | 0.76% |
| 2019 FY | 421.52 Billion KRW | 6.71% |
| 2018 FY | 395.01 Billion KRW | 3.69% |
| 2018 Q4 | 395.01 Billion KRW | -1.99% |
| 2018 Q3 | 403.04 Billion KRW | 4.55% |
| 2018 Q2 | 385.49 Billion KRW | 1.26% |
| 2018 Q1 | 380.71 Billion KRW | -0.06% |
| 2017 Q2 | 354.58 Billion KRW | 6.27% |
| 2017 Q1 | 333.66 Billion KRW | 2.97% |
| 2017 FY | 380.94 Billion KRW | 17.56% |
| 2017 Q4 | 380.94 Billion KRW | 1.73% |
| 2017 Q3 | 374.46 Billion KRW | 5.61% |
| 2016 Q3 | 308.33 Billion KRW | 37.7% |
| 2016 Q1 | 210.36 Billion KRW | 3.35% |
| 2016 FY | 324.03 Billion KRW | 59.19% |
| 2016 Q2 | 223.92 Billion KRW | 6.45% |
| 2016 Q4 | 324.03 Billion KRW | 5.09% |
| 2015 FY | 203.55 Billion KRW | 20.79% |
| 2015 Q4 | 203.55 Billion KRW | 13.54% |
| 2015 Q3 | 179.28 Billion KRW | 3.85% |
| 2015 Q2 | 172.64 Billion KRW | 2.65% |
| 2015 Q1 | 168.19 Billion KRW | -0.19% |
| 2014 Q1 | 150.02 Billion KRW | 88.92% |
| 2014 Q3 | 165.88 Billion KRW | 13.63% |
| 2014 Q4 | 168.51 Billion KRW | 1.58% |
| 2014 FY | 168.51 Billion KRW | 112.19% |
| 2014 Q2 | 145.99 Billion KRW | -2.69% |
| 2013 Q3 | 73.8 Billion KRW | 1.48% |
| 2013 Q1 | 72.67 Billion KRW | 3.04% |
| 2013 FY | 79.41 Billion KRW | 12.59% |
| 2013 Q2 | 72.72 Billion KRW | 0.06% |
| 2013 Q4 | 79.41 Billion KRW | 7.61% |
| 2012 FY | 70.53 Billion KRW | 0.0% |
| 2012 Q4 | 70.53 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 18.637% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -520.215% |
| BINEX Co., Ltd. | 257.01 Billion KRW | -137.975% |
| Bioneer Corporation | 315.48 Billion KRW | -93.866% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -309.299% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | -36.1% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -151.577% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -169.106% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 64.555% |
| Peptron, Inc. | 52.49 Billion KRW | -1065.085% |
| Amicogen, Inc. | 467.09 Billion KRW | -30.941% |
| Genexine, Inc. | 376.58 Billion KRW | -62.412% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -204.601% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -222.752% |
| ALTEOGEN Inc. | 256.09 Billion KRW | -138.822% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | -14.262% |
| SillaJen, Inc. | 76.71 Billion KRW | -697.267% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -142.566% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -494.819% |
| Genomictree Inc. | 132.84 Billion KRW | -360.407% |
| MedPacto, Inc. | 80.47 Billion KRW | -660.022% |
| D&D Pharmatech | 79.2 Billion KRW | -672.215% |
| EASY BIO,Inc. | 172.04 Billion KRW | -255.509% |
| GI Innovation, Inc. | 81.34 Billion KRW | -651.932% |